Pediatric Melanoma and Drug Development
Importance-Pediatric melanoma occurs, albeit rarely. Should patients be treated by today's medical standards, or be subjected to medically unnecessary clinical studies? Observations-We identified international, industry-sponsored pediatric melanoma studies triggered by regulatory demands in www...
Saved in:
Main Authors: | Klaus Rose (Author), Jane M. Grant-Kels (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia
by: Klaus Rose, MD, MS, et al.
Published: (2019) -
The Challenges of Pediatric Drug Development
by: Klaus Rose, MD, MS
Published: (2019) -
Acral lentiginous melanoma in situ with a characteristically benign dermatoscopic parallel-furrow pattern
by: Shifa Akhtar, BS, et al.
Published: (2022) -
Cutaneous melanoma in women
by: Mi Ryung Roh, MD, et al.
Published: (2015) -
Cutaneous melanoma in women
by: Mi Ryung Roh, MD, et al.
Published: (2017)